Skip to content
10-Q

Quarterly Report

ADMA BIOLOGICS, INC. ADMA

0001140361-25-040578

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 238M sh
Shares Diluted Q3 2025 · Sep 30, 2025 244.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 245.49M sh
Shares Diluted Q3 2025 · Sep 30, 2024 244.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 241.77M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $23.04M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $21.49M
Capex Q3 2025 · Sep 30, 2024 $5.47M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $14.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $68.46M
Long Term Debt Q3 2025 · Sep 30, 2025 $70.08M
Long Term Debt Q3 2025 · Dec 31, 2024 $72.34M
Short Term Debt Q3 2025 · Sep 30, 2025 $2.34M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $61.39M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $103.15M
Stockholders Equity Q3 2025 · Sep 30, 2025 $431.19M
Stockholders Equity Q3 2025 · Jun 30, 2025 $398.33M
Stockholders Equity Q3 2025 · Mar 31, 2025 $373.42M
Stockholders Equity Q3 2025 · Dec 31, 2024 $349.02M
Stockholders Equity Q3 2025 · Sep 30, 2024 $231.89M
Stockholders Equity Q3 2025 · Jun 30, 2024 $188.27M
Stockholders Equity Q3 2025 · Mar 31, 2024 $153.71M
Stockholders Equity Q3 2025 · Dec 31, 2023 $135.21M
Current Liabilities Q3 2025 · Sep 30, 2025 $56.49M
Current Liabilities Q3 2025 · Dec 31, 2024 $55.54M
Total Liabilities Q3 2025 · Sep 30, 2025 $137.5M
Total Liabilities Q3 2025 · Dec 31, 2024 $139.66M
Current Assets Q3 2025 · Sep 30, 2025 $402.66M
Current Assets Q3 2025 · Dec 31, 2024 $331.41M
Total Assets Q3 2025 · Sep 30, 2025 $568.69M
Total Assets Q3 2025 · Dec 31, 2024 $488.68M
Total Assets Q3 2025 · Sep 30, 2024 $390.62M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.15
Eps Diluted Q3 2025 · Sep 30, 2025 $0.40
Eps Diluted Q3 2025 · Sep 30, 2024 $0.15
Eps Diluted Q3 2025 · Sep 30, 2024 $0.35
Eps Basic Q3 2025 · Sep 30, 2025 $0.15
Eps Basic Q3 2025 · Sep 30, 2025 $0.41
Eps Basic Q3 2025 · Sep 30, 2024 $0.15
Eps Basic Q3 2025 · Sep 30, 2024 $0.37
Sga Expense Q3 2025 · Sep 30, 2025 $21.78M
Sga Expense Q3 2025 · Sep 30, 2025 $68.07M
Sga Expense Q3 2025 · Sep 30, 2024 $18.56M
Sga Expense Q3 2025 · Sep 30, 2024 $50.81M
Rd Expense Q3 2025 · Sep 30, 2025 $1.53M
Rd Expense Q3 2025 · Sep 30, 2025 $3.39M
Rd Expense Q3 2025 · Sep 30, 2024 $412K
Rd Expense Q3 2025 · Sep 30, 2024 $1.42M
Net Income Q3 2025 · Sep 30, 2025 $36.43M
Net Income Q3 2025 · Sep 30, 2025 $97.55M
Net Income Q3 2025 · Jun 30, 2025 $34.22M
Net Income Q3 2025 · Mar 31, 2025 $26.9M
Net Income Q3 2025 · Sep 30, 2024 $35.91M
Net Income Q3 2025 · Sep 30, 2024 $85.78M
Net Income Q3 2025 · Jun 30, 2024 $32.06M
Net Income Q3 2025 · Mar 31, 2024 $17.81M
Operating Income Q3 2025 · Sep 30, 2025 $51.01M
Operating Income Q3 2025 · Sep 30, 2025 $128.69M
Operating Income Q3 2025 · Sep 30, 2024 $39.64M
Operating Income Q3 2025 · Sep 30, 2024 $100.66M
Gross Profit Q3 2025 · Sep 30, 2025 $75.63M
Gross Profit Q3 2025 · Sep 30, 2025 $203.95M
Gross Profit Q3 2025 · Sep 30, 2024 $59.66M
Gross Profit Q3 2025 · Sep 30, 2024 $156.22M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $58.6M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $167.06M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $60.18M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $152.69M
Revenue Q3 2025 · Sep 30, 2025 $134.22M
Revenue Q3 2025 · Sep 30, 2025 $371.01M
Revenue Q3 2025 · Sep 30, 2024 $119.84M
Revenue Q3 2025 · Sep 30, 2024 $308.91M